Hodgkin Lymphoma, Version 2.2022 Featured Updates to the NCCN Guidelines

被引：57

作者：

Hoppe, Richard T. ^{[1
]}

Advani, Ranjana H. ^{[1
]}

Ai, Weiyun Z. ^{[2
]}

Ambinder, Richard F. ^{[3
]}

Armand, Philippe ^{[4
]}

Bello, Celeste M. ^{[5
]}

Benitez, Cecil M. ^{[6
]}

Chen, Weina ^{[7
]}

Dabaja, Bouthaina ^{[8
]}

Daly, Megan E. ^{[9
]}

Gordon, Leo I. ^{[10
]}

Hansen, Neil ^{[11
]}

Herrera, Alex F. ^{[12
]}

Hochberg, Ephraim P. ^{[13
]}

Johnston, Patrick B. ^{[14
]}

Kaminski, Mark S. ^{[15
]}

Kelsey, Christopher R. ^{[16
]}

Kenkre, Vaishalee P. ^{[17
]}

Khan, Nadia ^{[18
]}

Lynch, Ryan C. ^{[19
]}

Maddocks, Kami ^{[20
,21
]}

McConathy, Jonathan ^{[22
]}

Metzger, Monika ^{[23
]}

Morgan, David ^{[24
]}

Mulroney, Carolyn ^{[25
]}

Pullarkat, Sheeja T. ^{[5
]}

Rabinovitch, Rachel ^{[26
]}

Rosenspire, Karen C. ^{[27
]}

Seropian, Stuart ^{[28
]}

Tao, Randa ^{[29
]}

Torka, Pallawi ^{[30
]}

Winter, Jane N.

Yahalom, Joachim ^{[31
]}

Yang, Joanna C. ^{[32
,33
]}

Burns, Jennifer L. ^{[34
]}

Campbell, Mallory ^{[34
]}

Sundar, Hema ^{[34
]}

机构：

[1] Stanford Canc Inst, Stanford, CA 94305 USA

[2] UCSF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[3] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[4] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[6] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[7] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA

[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[9] Univ Calif Davis, Comprehens Canc Ctr, Davis, CA USA

[10] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[11] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[12] City Hope Natl Med Ctr, Duarte, CA USA

[13] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[14] Mayo Clin, Canc Ctr, Rochester, MN USA

[15] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[16] Duke Canc Inst, Durham, NC USA

[17] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[18] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[19] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA

[20] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[21] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA

[22] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[23] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[24] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[25] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA

[26] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[27] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[28] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[29] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[30] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA

[31] Mem Sloan Kettering Canc Ctr, New York, NY USA

[32] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[33] Washington Univ, Sch Med, St Louis, MO 14263 USA

[34] Natl Comprehens Canc Network, Ft Washington, MD USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2022年 / 20卷 / 04期

关键词：

STEM-CELL TRANSPLANTATION; INTENSITY-MODULATED RADIOTHERAPY; MEDIASTINAL RADIATION-THERAPY; INVOLVED-NODE RADIOTHERAPY; BRENTUXIMAB VEDOTIN; PHASE-II; SINGLE-ARM; OPEN-LABEL; FOLLOW-UP; DISEASE;

D O I：

10.6004/jnccn.2022.0021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hodgkin lymphoma (HL) is an uncommon malignancy of B-cell origin. Classical HL (cHL) and nodular lymphocyte-predominant HL are the 2 main types of HL. The cure rates for HL have increased so markedly with the advent of modern treatment options that overriding treatment considerations often relate to long-term toxicity. These NCCN Guidelines Insights discuss the recent updates to the NCCN Guidelines for HL focusing on (1) radiation therapy dose constraints in the management of patients with HL, and (2) the management of advanced-stage and relapsed or refractory cHL.

引用

页码：323 / 334

页数：12

共 75 条

[1] Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results [J].

Advani, Ranjana H. ;

Moskowitz, Alison J. ;

Bartlett, Nancy L. ;

Vose, Julie M. ;

Ramchandren, Radhakrishnan ;

Feldman, Tatyana A. ;

LaCasce, Ann S. ;

Christian, Beth A. ;

Ansell, Stephen M. ;

Moskowitz, Craig H. ;

Brown, Lisa ;

Zhang, Chiyu ;

Taft, David ;

Ansari, Sahar ;

Sacchi, Mariana ;

Ho, Linda ;

Herrera, Alex F. .

BLOOD, 2021, 138 (06) :427-438

[2] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].

Ansell, Stephen M. ;

Lesokhin, Alexander M. ;

Borrello, Ivan ;

Halwani, Ahmad ;

Scott, Emma C. ;

Gutierrez, Martin ;

Schuster, Stephen J. ;

Millenson, Michael M. ;

Cattry, Deepika ;

Freeman, Gordon J. ;

Rodig, Scott J. ;

Chapuy, Bjoern ;

Ligon, Azra H. ;

Zhu, Lili ;

Grosso, Joseph F. ;

Kim, Su Young ;

Timmerman, John M. ;

Shipp, Margaret A. ;

Armand, Philippe .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319

[3] Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial [J].

Armand, Philippe ;

Engert, Andreas ;

Younes, Anas ;

Fanale, Michelle ;

Santoro, Armando ;

Zinzani, Pier Luigi ;

Timmerman, John M. ;

Collins, Graham P. ;

Ramchandren, Radhakrishnan ;

Cohen, Jonathon B. ;

De Boer, Jan Paul ;

Kuruvilla, John ;

Savage, Kerry J. ;

Trneny, Marek ;

Shipp, Margaret A. ;

Kato, Kazunobu ;

Sumbul, Anne ;

Farsaci, Benedetto ;

Ansell, Stephen M. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) :1428-+

[4] Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure [J].

Armand, Philippe ;

Shipp, Margaret A. ;

Ribrag, Vincent ;

Michot, Jean-Marie ;

Zinzani, Pier Luigi ;

Kuruvilla, John ;

Snyder, Ellen S. ;

Ricart, Alejandro D. ;

Balakumaran, Arun ;

Rose, Shelonitda ;

Moskowitz, Craig H. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) :3733-+

[5] Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer [J].

Atkins, Katelyn M. ;

Chaunzwa, Tafadzwa L. ;

Lamba, Nayan ;

Bitterman, Danielle S. ;

Rawal, Bhupendra ;

Bredfeldt, Jeremy ;

Williams, Christopher L. ;

Kozono, David E. ;

Baldini, Elizabeth H. ;

Nohria, Anju ;

Hoffmann, Udo ;

Aerts, Hugo J. W. L. ;

Mak, Raymond H. .

JAMA ONCOLOGY, 2021, 7 (02) :206-219

[6] Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804 [J].

Bartlett, N. L. ;

Niedzwiecki, D. ;

Johnson, J. L. ;

Friedberg, J. W. ;

Johnson, K. B. ;

van Besien, K. ;

Zelenetz, A. D. ;

Cheson, B. D. ;

Canellos, G. P. .

ANNALS OF ONCOLOGY, 2007, 18 (06) :1071-1079

[7] PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group [J].

Borchmann, Peter ;

Goergen, Helen ;

Kobe, Carsten ;

Lohri, Andreas ;

Greil, Richard ;

Eichenauer, Dennis A. ;

Zijlstra, Josee M. ;

Markova, Jana ;

Meissner, Julia ;

Feuring-Buske, Michaela ;

Huttmann, Andreas ;

Dierlamm, Judith ;

Soekler, Martin ;

Beck, Hans-Joachim ;

Willenbacher, Wolfgang ;

Ludwig, Wolf-Dieter ;

Pabst, Thomas ;

Topp, Max S. ;

Hitz, Felicitas ;

Bentz, Martin ;

Keller, Ulrich Bernd ;

Kuhnhardt, Dagmar ;

Ostermann, Helmut ;

Schmitz, Norbert ;

Hertenstein, Bernd ;

Aulitzky, Walter ;

Maschmeyer, Georg ;

Vieler, Tom ;

Eich, Hans ;

Baues, Christian ;

Stein, Harald ;

Fuchs, Michael ;

Kuhnert, Georg ;

Diehl, Volker ;

Dietlein, Markus ;

Engert, Andreas .

LANCET, 2017, 390 (10114) :2790-2802

[8] CHEMOTHERAPY OF ADVANCED HODGKINS-DISEASE WITH MOPP, ABVD, OR MOPP ALTERNATING WITH ABVD [J].

CANELLOS, GP ;

ANDERSON, JR ;

PROPERT, KJ ;

NISSEN, N ;

COOPER, MR ;

HENDERSON, ES ;

GREEN, MR ;

GOTTLIEB, A ;

PETERSON, BA .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1478-1484

[9] PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study [J].

Casasnovas, Rene-Olivier ;

Bouabdallah, Reda ;

Brice, Pauline ;

Lazarovici, Julien ;

Ghesquieres, Herve ;

Stamatoullas, Aspasia ;

Dupuis, Jehan ;

Gac, Anne-Claire ;

Gastinne, Thomas ;

Joly, Bertrand ;

Bouabdallah, Krimo ;

Nicolas-Virelizier, Emmanuelle ;

Feugier, Pierre ;

Morschhauser, Franck ;

Delarue, Richard ;

Farhat, Hassan ;

Quittet, Philippe ;

Berriolo-Riedinger, Alina ;

Ternpescul, Adrian ;

Edeline, Veronique ;

Maisonneuve, Nerve ;

Fomecker, Luc-Matthieu ;

Lamy, Thiery ;

Delmer, Alain ;

Dartigues, Peggy ;

Martin, Laurent ;

Andre, Marc ;

Moonier, Nicolas ;

Traverse-Glehen, Alexandra ;

Meignan, Michel .

LANCET ONCOLOGY, 2019, 20 (02) :202-215

[10] Active breathing control for patients receiving mediastinal radiation therapy for lymphoma: Impact on normal tissue dose [J].

Charpentier, Anne-Marie ;

Conrad, Tatiana ;

Sykes, Jenna ;

Ng, Angela ;

Zhou, Rachel ;

Parent, Amy ;

Coolens, Catherine ;

Tsang, Richard W. ;

Gospodarowicz, Mary K. ;

Sun, Alexander ;

Hodgson, David C. .

PRACTICAL RADIATION ONCOLOGY, 2014, 4 (03) :174-180

← 1 2 3 4 5 6 7 8 →